Eli Lilly Says Omvoh Phase 3 Study Met Goal in Children

Eli Lilly said 81% of patients ages 4 to 17 with moderately to severely active ulcerative colitis achieved clinical response to Omvoh induction at week 12. The study reported clinical, symptomatic and endoscopic outcomes.